[show abstract]
[hide abstract]
ABSTRACT: Highly potent and selective substrate analogue factor Xa inhibitors were obtained by incorporation of non-basic or modestly basic P1 residues known from the development of thrombin inhibitors. The modification of the P2 and P3 amino acids strongly influenced the selectivity and provided potent dual factor Xa and thrombin inhibitors without affecting the fibrinolytic enzymes. Several inhibitors demonstrated excellent anticoagulant efficacy in standard clotting assays in human plasma.
Bioorganic & Medicinal Chemistry Letters 07/2007; 17(12):3322-9. · 2.55 Impact Factor
